1. Search Result
Search Result
Results for "

cul4

" in MedChemExpress (MCE) Product Catalog:

28

Inhibitors & Agonists

2

Peptides

9

Recombinant Proteins

1

Isotope-Labeled Compounds

5

Antibodies

6

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-14658
    Thalidomide
    Maximum Cited Publications
    25 Publications Verification

    Ligands for E3 Ligase Autophagy Apoptosis Molecular Glues Inflammation/Immunology Cancer
    Thalidomide inhibits cereblon (CRBN), a part of the cullin-4 E3 ubiquitin ligase complex CUL4-RBX1-DDB1, with a Kd of ∼250 nM, and has immunomodulatory, anti-inflammatory and anti-angiogenic cancer properties. Thalidomide can work as molecular glue to potentiate substrate.
    Thalidomide
  • HY-14571
    E7820
    5 Publications Verification

    ER68203-00

    Molecular Glues Integrin Infection Metabolic Disease Cancer
    E7820 (ER68203-00), an orally active aromatic sulfonamide derivative, is a molecular glue that induces the targeted degradation of splicing factor RBM39 by recruiting the E3 ubiquitin ligase CUL4-RBX1-DDB1-DCAF15 (CRL4 DCAF15). E7820 is an angiogenesis inhibitor suppressing an expression of integrin alpha2 subunit on endothelium. E7820 inhibits rat aorta angiogenesis with an IC50 of 0.11 μg/ml. E7820 modulates α-1, α-2, α-3, and α-5 integrin mRNA expression. E7820 can be used for the study of acute myeloid leukemia (AML) .
    E7820
  • HY-156828

    Molecular Glues Epigenetic Reader Domain Cancer
    MMH2 is a novel BRD4 molecular glue degrader that functions by recruiting the CUL4 and DCAF16 ligases to the second bromodomain of BRD4 (BRD4BD2) .
    MMH2
  • HY-156827

    Molecular Glues Epigenetic Reader Domain Cancer
    MMH1 is a novel BRD4 molecular glue degrader that functions by recruiting the CUL4 and DCAF16 ligases to the second bromodomain of BRD4 (BRD4BD2) .
    MMH1
  • HY-170859

    PROTACs Casein Kinase Cancer
    AH078 is a PROTAC-based CK1δ/ε degrader (DC50=0.55 μM, Dmax=70%) that lacks subtype selectivity between CK1δ and CK1ε. AH078 induces target protein degradation either by recruiting the CUL4-CRBN E3 ligase complex and proteasome, or via the VHL- and ubiquitin-dependent pathway. AH078 also exhibits selectivity for CK1α, and is widely applicable to research related to colon cancer, pancreatic cancer, breast cancer, ovarian cancer, chronic lymphocytic leukemia, acute myeloid leukemia, glioma, and metastatic breast adenocarcinoma .
    AH078
  • HY-14658R

    Ligands for E3 Ligase Autophagy Apoptosis Reference Standards Inflammation/Immunology Cancer
    Thalidomide (Standard) is the analytical standard of Thalidomide. This product is intended for research and analytical applications. Thalidomide inhibits cereblon (CRBN), a part of the cullin-4 E3 ubiquitin ligase complex CUL4-RBX1-DDB1, with a Kd of ∼250 nM, and has immunomodulatory, anti-inflammatory and anti-angiogenic cancer properties. Thalidomide can work as molecular glue to potentiate substrate.
    Thalidomide (Standard)
  • HY-175756

    Molecular Glues SWI/SNF Complex Cancer
    SMARCA2/4 degrader-1 is a SMARCA2/4 molecular glue degrader with a DCAF16 EC50 of 110 nM. SMARCA2/4 degrader-1 covalently adducts at cysteine to form a ternary complex with SMARCA2/4 and recruits CUL4 DCAF16 and CRL1 FBXO22 E3 ligase complexes. SMARCA2/4 degrader-1 induces ubiquitination and proteasomal degradation of SMARCA2/4. SMARCA2/4 degrader-1 can be used for research of SMARCA4-deficient malignancies, non-small cell lung cancer (NSCLC), and colorectal cancer .
    SMARCA2/4 degrader-1
  • HY-161166

    Others Others
    MM-02-57 is a covalent DDB1 CUL4A adaptor protein recruiter .
    MM-02-57
  • HY-148602
    KH-4-43
    1 Publications Verification

    E1/E2/E3 Enzyme Cancer
    KH-4-43 is an inhibitor of E3 CRL4. KH-4-43 inhibits E3 CRL4's core ligase complex and exhibits anticancer activity. KH-4-43 has a binding Kd to E3 ROC1-CUL4A CTD or the highly related ROC1-CUL1 CTD at 83 nM or 9.4 μM, respectively .
    KH-4-43
  • HY-14658S

    Molecular Glues Ligands for E3 Ligase Autophagy Apoptosis Inflammation/Immunology Cancer
    Thalidomide-d4 is a deuterium labeled Thalidomide. Thalidomide inhibits cereblon (CRBN), a part of the cullin-4 E3 ubiquitin ligase complex CUL4-RBX1-DDB1, with a Kd of ~250 nM, and has immunomodulatory, anti-inflammatory and anti-angiogenic cancer properties .
    Thalidomide-d4
  • HY-175187

    CDK E1/E2/E3 Enzyme Cancer
    LO-3-63, a Ribociclib (HY-15777) analog bearing a truncated fumaramide handle, is a PROTAC-like CDK4/6 degrader. LO-3-63 induces CUL4 DCAF16-dependent degradation of CDK4/6 in cells .
    LO-3-63
  • HY-150184

    DNA/RNA Synthesis Cancer
    And1-IN-1 is a potent And1 inhibitor with an IC50 of 2.08 μM. And1-IN-1 binds to the N-terminus of And-1 and induces a conformational change in And-1, which promotes the interaction of And-1 with E3 ligase CUL4B for ubiquitin-mediated degradation. And1-IN-1 suppresses the growth of a broad range of cancers and resensitizes platinum-resistant ovarian cancer cells to platinum agents. And1-IN-1 can be used for the studies of ovarian cancer and breast cancer .
    And1-IN-1
  • HY-176070

    Epigenetic Reader Domain Cancer
    HRG038 is a selective covalent BRD4 degrader. HRG038 binds covalently to the E3 ubiquitin ligase CUL4 DCAF16, recruiting it to BRD4, leading to the ubiquitination and subsequent proteasomal degradation of BRD4. HRG038 is promising for research of cancers .
    HRG038
  • HY-157592

    Molecular Glues Epigenetic Reader Domain Cancer
    MMH2-NR a negtive control of MMH2. MMH2 is a CUL4-associated factor (DCAF16)-based bromodomain protein 4 (BRD4) degrader .
    MMH2-NR
  • HY-173274

    Molecular Glues Cancer
    CB039 is a selective a molecular glue degrader that targets RBM39 (RNA-binding protein 39). CB039 promotes the formation of a ternary complex between RBM39 and the E3 ubiquitin ligase CUL4-DCAF15, leading to proteasomal degradation of RBM39. CB039 is promising for research of cancers with RBM39 dependency, such as acute myeloid leukemia (AML) and ovarian cancer .
    CB039
  • HY-176067

    Androgen Receptor Cancer
    LO-4-25 is a covalent degrader targeting the androgen receptor (AR) and its truncated variant AR-V7. LO-4-25 covalently binds to the E3 ubiquitin ligase CUL4 DCAF16, promoting the ubiquitination of AR and AR-V7, which subsequently are recognized and degraded by the proteasome, reducing the protein levels of AR and AR-V7 in cells. LO-4-25 is promising for research of androgen-independent prostate cancers .
    LO-4-25
  • HY-157591

    Molecular Glues Epigenetic Reader Domain Cancer
    MMH1-NR, containing a non-reactive (ethyl) group is a negative control of MMH1. MMH1 is a CUL4-associated factor (DCAF16)-based bromodomain protein 4 (BRD4) degrader .
    MMH1-NR
  • HY-P11028

    CDK Cancer
    M1-20 is a CDK1 inhibitor. M1-20 promotes CDK1 ubiquitination by CUL4-DDB1-DCAF1 complexes and degradation through the proteasome pathway. M1-20 abolishes the formation of CDK1/CCNB1 complexes. M1-20 has significant anticancer activity of spontaneous breast cancer in FVB/N MMTV-PyVT mice model .
    M1-20
  • HY-175179

    Epigenetic Reader Domain E1/E2/E3 Enzyme Cancer
    LO-3-61, a JQ-1 (HY-13030) analog bearing a truncated fumaramide handle, is a PROTAC (proteolysis-targeting chimeras)-like BRD4 degrader. LO-3-61 degrades both the long and short isoforms of BRD4 CUL4DcAr16-dependently in cells. LO-3-61 shows selectivity for BRD3 and BRD4 degradation in MDA-MB-231 cells .
    LO-3-61
  • HY-RS28983

    Small Interfering RNA (siRNA) Others
    Cul4a Rat Pre-designed siRNA Set A contains three designed siRNAs for Cul4a gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
    Cul4a Rat Pre-designed siRNA Set A
    Cul4a Rat Pre-designed siRNA Set A
  • HY-RS03362

    Small Interfering RNA (siRNA) Others

    CUL4A Human Pre-designed siRNA Set A contains three designed siRNAs for CUL4A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    CUL4A Human Pre-designed siRNA Set A
    CUL4A Human Pre-designed siRNA Set A
  • HY-RS03363

    Small Interfering RNA (siRNA) Others

    CUL4B Human Pre-designed siRNA Set A contains three designed siRNAs for CUL4B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    CUL4B Human Pre-designed siRNA Set A
    CUL4B Human Pre-designed siRNA Set A
  • HY-RS28984

    Small Interfering RNA (siRNA) Others
    Cul4b Rat Pre-designed siRNA Set A contains three designed siRNAs for Cul4b gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
    Cul4b Rat Pre-designed siRNA Set A
    Cul4b Rat Pre-designed siRNA Set A
  • HY-169389

    PROTACs WDR5 Cancer
    OICR41114 is a WDR5 PROTAC degrader with an EC50 of 40 nM. OICR41114 binds both DCAF1 and WDR5, and its binding affinity for DCAF1 is significantly enhanced in the presence of WDR5 (KD increases from 59 nM to 5 nM). OICR41114 exerts antiproliferative effects on MV4-11 cells. OICR41114 can be used for the research of acute myeloid leukemia .
    OICR41114
  • HY-RS22460

    Small Interfering RNA (siRNA) Others

    Cul4a Mouse Pre-designed siRNA Set A contains three designed siRNAs for Cul4a gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Cul4a Mouse Pre-designed siRNA Set A
    Cul4a Mouse Pre-designed siRNA Set A
  • HY-RS22461

    Small Interfering RNA (siRNA) Others

    Cul4b Mouse Pre-designed siRNA Set A contains three designed siRNAs for Cul4b gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Cul4b Mouse Pre-designed siRNA Set A
    Cul4b Mouse Pre-designed siRNA Set A
  • HY-181164

    PROTACs Epigenetic Reader Domain HIV Infection
    PROTAC BRD4 Degrader-43 is a BRD4 PROTAC degrader. PROTAC BRD4 Degrader-43 recruits the DCAF1-DDB1-Cul4A E3 ligase complex via a Vpr-derived peptide moiety to induce BRD4 ubiquitination and degradation through the ubiquitin-proteasome system. PROTAC BRD4 Degrader-43 exhibits potent HIV latency-reversing activity. PROTAC BRD4 Degrader-43 can be used for the research of HIV-1 latent infection . (Pink: BRD4 ligand (HY-13030); Blue: Cul4A-DDB1-DCAF1 ligand (HY-P11640); Black: conjugate of PEG linker + cell-penetrating peptide (HY-P2483))
    PROTAC BRD4 Degrader-43
  • HY-P11640

    Ligands for E3 Ligase HIV Infection
    Vpr (1-14) is a viral protein R and acts as an accessory protein of HIV-1. Vpr (1-14) can binds to Cul4A-DDB1-DCAF1 E3 ligase complex and can be used as an E3 ligase-binding component in PROTACs. Vpr (1-14) can be used to synthesize PROTAC BRD4 Degrader-43 (HY-181164) .
    Vpr (1-14)

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: